PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2024Journal of Primary Health Care2 citationsOpen Access

Ashwagandha

View Full Paper
XLXin Yi LimJBJoanne Barnes

Key Points

Key points are not available for this paper at this time.

Abstract

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of The Royal New Zealand College of General Practitioners. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lim et al. (2024) studied this question.

synapsesocial.com/papers/68e7b7dcb6db64358770e626https://doi.org/10.1071/hc23172
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 1879 Ashwagandha, a herbal product used as a neuroprotective agent2024
  2. 2Safety of 12‐Months Administration of Ashwagandha (<scp><i>Withania somnifera</i></scp>) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study2025
  3. 3A clinical assessment of the therapeutic effects of Ashwagandha root extract on cognitive performance, sleep, and fatigue in children aged 6–12 years2026
  4. 4Ashwagandha-Withania somnifera for Sustainable Socioeconomic Empowerment2024
  5. 5Ashwagandha under fire: A critical scientific analysis of regulatory decisions2024